CTOs on the Move

Intellisphere

www.hcplive.com

 
Intellisphere is a Plainsboro, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $500M-1 Billion
  • www.hcplive.com
  • 666 Plainsboro Rd
    Plainsboro, NJ USA 08536
  • Phone: 609.716.7777

Executives

Name Title Contact Details

Similar Companies

Sunrise Healthcare Ctr

Sunrise Healthcare Ctr is a Anaheim, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Willis-Knighton Health System

Willis-Knighton Health System, headquartered in Shreveport, Louisiana, is a not-for-profit community healthcare corporation with four general acute care hospitals and affiliate relationships with several rural hospitals. It is the largest nongovernmental employer in the region, employing more than 6,500 people.

Vesta Healthcare

At Vesta Healthcare, we believe that improving quality of life is possible when we connect technology with clinical expertise, and caregivers and care recipients with the care team.

Thriveworks

At Thriveworks, we believe that everyone can benefit from counseling or coaching with a skilled and caring professional. That`s why Thriveworks was founded—to help persons seeking counseling or coaching gain access to truly exceptional providers. Providers with a passion for helping each client make meaningful and extraordinary advances in his/her life, career, relationships, and happiness. We`re extremely selective about the counselors, psychologists, coaches, and psychiatrists that bear the “Thriveworks” name. Contact us to learn how a partnership with a caring and experienced counselor or coach can help you.

ProKidney

ProKidney, a pioneer in the treatment of chronic kidney disease (CKD) through innovations in cellular therapy, was founded in 2015 after a decade of research. ProKidney`s lead product candidate, REACT® (Renal Autologous Cell Therapy), is a first-of-its-kind, patented disease-modifying autologous cellular therapy with the potential to not only slow and stabilize the progression of CKD, but in some cases drive meaningful improvement in kidney function. REACT® has received Regenerative Medicine Advanced Therapy (RMAT) designation, as well as FDA and EMA guidance, supporting an immediate start to a global registrational program, which launched in the United States on schedule in January 2022. On January 18, 2022, ProKidney announced that it would become a publicly traded company via a business combination with Social Capital Suvretta Holdings Corp. III